Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.210
-0.004 (-2.05%)
At close: Dec 20, 2024, 4:00 PM
0.228
+0.018 (8.33%)
After-hours: Dec 20, 2024, 7:49 PM EST
Viracta Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -43.29 | -51.06 | -49.2 | -114.76 | -19.02 | -13.56 | |
| Depreciation & Amortization | 0.44 | 0.49 | 0.21 | 0.18 | 0.03 | 0 | |
| Other Amortization | - | - | - | - | - | 1.61 | |
| Asset Writedown & Restructuring Costs | - | - | - | 88.48 | - | -0.01 | |
| Loss (Gain) From Sale of Investments | -1.16 | -2.05 | -0.63 | - | - | - | |
| Stock-Based Compensation | 6.25 | 7.65 | 13.55 | 5.54 | 0.35 | 0.63 | |
| Other Operating Activities | - | - | - | 0.03 | 0.01 | -0.04 | |
| Change in Accounts Payable | -0.55 | -0.1 | -0.36 | 0.92 | 0.97 | 0.9 | |
| Change in Other Net Operating Assets | 3.51 | 5.18 | 0.97 | 0.76 | 1.6 | 0.09 | |
| Operating Cash Flow | -34.8 | -39.89 | -35.46 | -18.85 | -16.05 | -10.38 | |
| Capital Expenditures | - | -0.14 | -0.05 | -0.25 | -0.06 | - | |
| Cash Acquisitions | - | - | - | 17.14 | - | - | |
| Sale (Purchase) of Intangibles | - | - | - | -4 | - | - | |
| Investment in Securities | 43.33 | 15.14 | -53.82 | - | - | - | |
| Investing Cash Flow | 43.33 | 15 | -53.87 | 12.89 | -0.06 | - | |
| Long-Term Debt Issued | - | - | 19.99 | - | 5.26 | - | |
| Total Debt Issued | - | - | 19.99 | - | 5.26 | - | |
| Long-Term Debt Repaid | - | - | - | -0.23 | - | - | |
| Net Debt Issued (Repaid) | -8.6 | - | 19.99 | -0.23 | 5.26 | - | |
| Issuance of Common Stock | 0.34 | 0.44 | 2.56 | 62.66 | 0.85 | 0.01 | |
| Financing Cash Flow | -8.26 | 0.44 | 22.54 | 62.43 | 44.98 | 24.58 | |
| Net Cash Flow | 0.27 | -24.46 | -66.78 | 56.47 | 28.87 | 14.2 | |
| Free Cash Flow | -34.8 | -40.03 | -35.5 | -19.1 | -16.11 | -10.38 | |
| Free Cash Flow Per Share | -0.89 | -1.04 | -0.94 | -0.60 | -49.61 | -4.41 | |
| Cash Interest Paid | 3.13 | 3.07 | 0.45 | 0.34 | 0.12 | - | |
| Levered Free Cash Flow | -23.36 | -21.79 | -17.78 | -21.23 | -8.96 | -5.34 | |
| Unlevered Free Cash Flow | -21.37 | -19.47 | -17.42 | -20.92 | -8.82 | -5.91 | |
| Change in Net Working Capital | -1.45 | -4.21 | -0.49 | -2.18 | -2.61 | -0.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.